For the Inventor, By the Inventor

Enter assignee name

Madison, WI, United States of America

Ophidian Pharmaceuticals, Inc.

USPTO Granted Patents = 18

Forward Citations = 493

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Sean B Carroll (10 out of 15 patents)

John A Kink (5 out of 31 patents)

Christopher M Clemens (5 out of 6 patents)

4. James Arthur Williams (5 out of 53 patents)

5. Margaret B Van Boldrik (2 out of 4 patents)

6. Joseph R Firca (2 out of 4 patents)

7. Charles Vernon Pugh (1 out of 6 patents)

8. Meyer B Jackson (1 out of 5 patents)

9. Richard H Ffrench-Constant (1 out of 5 patents)

10. Katherine L Worledge (1 out of 4 patents)

11. Douglas C Stafford (1 out of 11 patents)

12. Bruce S Thalley (1 out of 3 patents)

13. Lisa Marie Byrne (1 out of 2 patents)

14. Mohammed Saleh Shekhani (1 out of 5 patents)

15. Allen Laughon (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 6290960 - Vaccine and antitoxin for the treatment of C. difficile disease (2001-09-18),

2. 6214343 - Prevention and treatment of necrotizing enterocolitis (2001-04-10),

3. 6080400 - Compositions for the prevention and treatment of verotoxin-induced (2000-06-27),

4. 6046165 - Compositions and methods for identifying and testing TGF-.beta. pathway (2000-04-04),

5. 6008046 - Drug and pesticide screening (1999-12-28),

6. 5998381 - Compounds that bind bacterial pili (1999-12-07),

7. 5919665 - Vaccine for clostridium botulinum neurotoxin (1999-07-06),

8. 5904922 - Treatment with polyvalent antivenom containing immunoglobulin which is (1999-05-18),

9. 5814477 - Recombinant clostridial toxin protein (1998-09-29),

10. 5762934 - Clostridium difficile toxin disease therapy (1998-06-09),

11. 5719267 - Clostridial toxin disease therapy (1998-02-17),

12. 5605691 - Immunologically active proteins from inclusion bodies (1997-02-25),

13. 5601823 - Avian antitoxins to clostridium difficle toxin A (1997-02-11),

14. 5599539 - Therapy for clostridial botulinum toxin (1997-02-04),

15. 5545721 - Conjugates for the prevention and treatment of sepsis (1996-08-13),

Ophidian Pharmaceuticals, Inc. is a leading biopharmaceutical company that specializes in developing innovative treatments for a variety of diseases. With a focus on research and development, Ophidian Pharmaceuticals is committed to improving patient outcomes and advancing medical science. The company's pipeline includes cutting-edge therapies for cancer, autoimmune disorders, and infectious diseases. Visit their website to learn more about their groundbreaking work.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#50 in Madison, WI

#414 in Wisconsin

#17,382 in US

#33,147 in the World

Madison, WI, United States of America

Ophidian Pharmaceuticals, Inc.

Forward Citations = 493

23 inventors:

Sean B Carroll (10 out of 15 patents)

John A Kink (5 out of 31 patents)

Christopher M Clemens (5 out of 6 patents)

4. James Arthur Williams (5 out of 53 patents)

5. Margaret B Van Boldrik (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…